DAWN
Day One Biopharmaceuticals, Inc.
Key Financials
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| SCHEDULE 13G/A | 5/14/2026 | View on SEC |
| 15-12G | 5/4/2026 | View on SEC |
| SCHEDULE 13D/A | 4/27/2026 | View on SEC |
| 4 | 4/27/2026 | View on SEC |
| 4 | 4/23/2026 | View on SEC |
| 4 | 4/23/2026 | View on SEC |
| 4 | 4/23/2026 | View on SEC |
| 4 | 4/23/2026 | View on SEC |
| 4 | 4/23/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | DAWN |
| Company Name | Day One Biopharmaceuticals, Inc. |
| CIK | 1845337 |
| Sector | Pharmaceutical Preparations |
| Industry | Large accelerated filer |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 650 484-0899 |